Anthony Scott Praill

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Anthony Scott Praill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony Scott Praill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kintara Therapeutics, Inc. Chief Financial Officer Common Stock 277,273 $187,714 $0.6770 01 Aug 2022 Direct
Kintara Therapeutics, Inc. Chief Financial Officer Option (right to buy) 720,260 01 Aug 2022 Direct

Insider Reports Filed by Anthony Scott Praill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HURA Kintara Therapeutics, Inc. 01 Aug 2022 2 $0 4 Chief Financial Officer 03 Aug 2022, 16:30
HURA Kintara Therapeutics, Inc. 08 Dec 2021 1 +$19,430 4 Chief Financial Officer 09 Dec 2021, 15:09